Isabel López

Neuronal levels and sequence of tau modulate the power of brain rhythms

S. Maeda, L. Mucke, B. Hu, 2018, Neurobiology of Disease.

Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer’s disease mutations but not by inhibition of BACE1

L. Mucke, J. Paz, J. Palop, 2020, Molecular Neurodegeneration.

Iduronate-2-sulfatase transport vehicle rescues behavioral and skeletal phenotypes in a mouse model of Hunter syndrome

T. Gill, K. Scearce-Levie, Elliot R. Thomsen, 2021, JCI insight.

Tau Reduction Prevents Key Features of Autism in Mouse Models

L. Mucke, Chao Tai, Weikun Guo, 2020, Neuron.

A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models

Nicholas E. Propson, K. Scearce-Levie, Steve Lianoglou, 2023, Nature Neuroscience.

Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia

Julie A. Harris, Jennifer D. Whitesell, K. Scearce-Levie, 2022, Molecular neurodegeneration.

Effects of fibroblast growth factor and glial-derived neurotrophic factor on akinesia, F-DOPA uptake and dopamine cells in parkinsonian primates.

A. Cools, K. Leenders, J. Pruim, 2002, Parkinsonism & related disorders.

Neuronal levels and sequence of tau modulate the power of brain rhythms

S. Maeda, L. Mucke, B. Hu, 2018, Neurobiology of Disease.